Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  UCB SA    UNC   BE0003739530

UCB SA (UNC)

Delayed Quote. Delayed CHI-X - 02/11 03:34:37 am
71 EUR   -0.65%
02/10 UCB : Enters into Research Agreement with Baylor College of Medicine
02/09 UCB : and Baylor College of Medicine launch strategic alliance in ne..
02/01 UCB : Executive Committee welcomes a new member
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Deutsche Boerse Ag
02/04/2016 02/05/2016 02/08/2016 02/09/2016 02/10/2016 Date
75.541(c) 75.006(c) 72.789(c) 69.125(c) 71.465(c) Last
101 0 0 0 199 Volume
-4.32% -0.71% -2.96% -5.03% +3.39% Change
More quotes
Financials (€)
Sales 2015 3 727 M
EBIT 2015 589 M
Net income 2015 445 M
Debt 2015 1 158 M
Yield 2015 1,58%
Sales 2016 3 993 M
EBIT 2016 666 M
Net income 2016 412 M
Debt 2016 1 128 M
Yield 2016 1,70%
P/E ratio 2015 30,13
P/E ratio 2016 32,24
EV / Sales 2015 4,04x
EV / Sales 2016 3,77x
Capitalization 13 909 M
More Financials
Company
UCB SA engages in the research, development, and commercialization of pharmaceutical and biotechnology products.It offers medicinal products for central nervous system and immunology disorders under the Cimzia, Xyzal, Zyrtec, Tussionex, Lortab, Vimpat, Keppra, and Neupro.The company was founded by... 
Sector
Pharmaceuticals
Calendar
02/26Earnings Release
More about the company
Surperformance© ratings of UCB SA
Trading Rating : Investor Rating :
More Ratings
Latest news on UCB SA
02/10 UCB : Enters into Research Agreement with Baylor College of Medicine
02/09 UCB : and Baylor College of Medicine launch strategic alliance in neurodegenerat..
02/01 UCB : Executive Committee welcomes a new member
02/01 UCB : new epilepsy drug BRIVIACT® receives EU approval
02/01 UCB : Transparency notification
01/11 UCB : Transparency notification
2015 UCB : New Findings from UCB Pharma SA in the Area of Economic Dynamics Described..
2015 UCB : Transparency notification from BlackRock Inc
More news
Sector news : Pharmaceuticals - NEC
02:28a HIKMA PHARMACEUTICALS : *hsbc cuts hikma pharmaceuticals price target to 2525 pe..
01:33a GLAXOSMITHKLINE : *ubs raises glaxosmithkline price target to 1420 pence - 'neut..
01:16a NOVARTIS : Sandoz advances its biosimilars program with EMA acceptance of regula..
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Chart UCB SA
Duration : Period :
UCB SA Technical Analysis Chart | UNC | BE0003739530 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions